Announced Thu, 22 May · 14:27 IST

Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve audited financial results ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sampre Nutritions Limited has informed BSE that its Board of Directors will meet on Friday, 30 May 2025. The main agenda is to consider and approve the audited standalone and consolidated financial results for the quarter and full year ended 31 March 2025. The intimation is filed under SEBI Listing Regulations by Managing Director Brahma Gurbani. No financial figures or detailed agenda items have been disclosed in this filing.

Likely market impact

This is a routine procedural filing and does not contain any financial data or material business decision. Investors should wait for the actual audited results to be announced on or after 30 May 2025 to assess the company's FY25 performance. No immediate impact on share price is expected from this intimation alone.